OC-0594: Postoperative [11C]MET-PET predicts radiochemotherapy outcome in glioblastoma: a prospective trial
OC-0594: Postoperative [11C]MET-PET predicts radiochemotherapy outcome in glioblastoma: a prospective trial
Krause, M.; Seidlitz, A.; Löck, S.; Jentsch, C.; Platzek, I.; Zöphel, K.; Petr, J.; van den Hoff, J.; Steinbach, J.; Krex, D.; Schackert, G.; Falk, M.; Baumann, M.; Beuthien-Baumann, B.
Abstract
Despite combined modality treatment involving surgery and adjuvant radiotherapy, a relevant percentage of chordoma and chondrosarcoma patients develop a local recurrence. In a previous study, we identified optic apparatus and/or brainstem compression, histology and GTV volume as prognostic factors for the risk of local failure. The present study aims to analyze patterns of recurrence and correlate local control with a detailed dosimetric analysis.
Beteiligte Forschungsanlagen
- PET-Zentrum
-
Vortrag (Konferenzbeitrag)
ESTRO 37, 20.04.2018, Barcelona, Spain
DOI: 10.1016/S0167-8140(18)30904-6 -
Beitrag zu Proceedings
ESTRO 37, 20.04.2018, Barcelona, Spain
Radiotherapy and Oncology, S310-S311
DOI: 10.1016/S0167-8140(18)30904-6
Permalink: https://www.hzdr.de/publications/Publ-27624